Emergency red cell exchange for the management of acute complications in sickle cell disease: Automated versus manual

被引:3
作者
Mihalca, Diana [1 ]
Ahmad, Adeel [1 ]
Mehta, Dipal [1 ]
Freeman, Tanya [1 ]
Orebayo, Funmilayo [1 ]
Bello-Sanyaolu, Oloruntoyin [1 ]
Lewis, Natasha [1 ]
Chatterjee, Basabi [1 ]
Tsitsikas, Dimitris A. [1 ]
机构
[1] Homerton Univ Hosp NHS Fdn Trust, Dept Haematol, Haemoglobinopathy Serv, London, England
关键词
acute sickle cell complications; automated red cell exchange transfusion; manual red cell exchange transfusion; sickle cell disease; TRANSFUSION;
D O I
10.1111/tme.12963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundRed blood cell exchange is the cornerstone of the management for acute complications of sickle cell disease. It improves anaemia and improvesperipheral tissue oxygen delivery while at the same time reduces the proportion of circulating sickle erythrocytes. Even though automated red cell exchange is very effective in rapidly lowering the Hb S level, 24-h availability is currently not feasible for most specialist centres including our own. ObjectiveHere, we describe our experience using both automated and manual red cell exchange for the management of acute sickle cell complications. MethodsEighty-six such episodes have been recorded between June 2011 and June 2022 comprising of 68 episodes of automated and 18 episodes of manual red cell exchange. ResultsThe post procedure Hb S/S + C level was 18% after automated and 36% after manual red cell exchange. The platelet count dropped by 41% and 21% after automated and manual red cell exchange respectively. The clinical outcomes including need for organ support, duration of stay in the intensive care unit and overall length of hospitalisation was comparable between the two groups. ConclusionIn our experience, manual red cell exchange is a safe and effective alternative to an automated procedure that can be used while specialist centres are building up their capacity to offer automated red cell exchange for all patients requiring the intervention.
引用
收藏
页码:287 / 289
页数:3
相关论文
共 5 条
[1]  
Ballas SK, 2019, ANN CLIN LAB SCI, V49, P836
[2]   Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion [J].
Davis, Bernard A. ;
Allard, Shubha ;
Qureshi, Amrana ;
Porter, John B. ;
Pancham, Shivan ;
Win, Nay ;
Cho, Gavin ;
Ryan, Kate .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (02) :192-209
[3]   A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients [J].
Kuo, Kevin H. M. ;
Ward, Richard ;
Kaya, Banu ;
Howard, Jo ;
Telfer, Paul .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) :425-428
[4]   Automated Red Cell Exchange in the Management of Sickle Cell Disease [J].
Tsitsikas, Dimitris A. ;
Badle, Saket ;
Hall, Rhys ;
Meenan, John ;
Bello-Sanyaolu, Oloruntoyin ;
Orebayo, Funmilayo ;
Abukar, Jibril ;
Elmi, Mohamed ;
Mulla, Afsana ;
Dave, Shalini ;
Lewis, Natasha ;
Sharma, Manisha ;
Chatterjee, Basabi ;
Amos, Roger J. .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) :1-13
[5]   Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance [J].
Willits, Iain ;
Cole, Helen ;
Jones, Roseanne ;
Carter, Kimberley ;
Arber, Mick ;
Jenks, Michelle ;
Craig, Joyce ;
Sims, Andrew .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (04) :455-468